Missed diagnostic testing has negative impact on lung cancer treatment
the ONA take:
A team of researchers from the Baptist Cancer Center and the University of Memphis, Tennessee, sought to identify the impact of factors associated with care delivery on prognosis for patients with lung cancer.
Their results show that only 1 in 10 patients with lung cancer underwent the recommended combination of diagnostic tests before surgery. In addition, patients waited 1.5 to 6 months to undergo surgery after suspicions of lung cancer are made via radiography.
Recommendations suggest three staging tests before surgery in patients for suspected lung cancer: computed tomography (CT), positron emission tomography (PET), and a biopsy.
According to the study results, 88% of patients did not undergo biopsy, no imaging test was obtained in 22% of patients, and no diagnostic procedure was done before surgery in 27% of patients.
The researchers conclude that delays in final treatment and missed diagnostic tests can hinder outcomes for patients with lung cancer.
Their results highlight the importance of engaging patients in their care from early on to determine the best tests that will lead to an optimal treatment course for that patient.
A team sought to identify the impact of factors associated with care delivery on prognosis for patients with lung cancer.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- LIVESTRONG Exercise Program Improves QoL in Cancer Survivors
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
- Profile of Tivantinib and its Potential in the Treatment of Hepatocellular Carcinoma: the evidence to date
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|